X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (59862) 59862
Newsletter (2803) 2803
Newspaper Article (1709) 1709
Book Chapter (401) 401
Magazine Article (231) 231
Transcript (66) 66
Web Resource (45) 45
Book / eBook (37) 37
Conference Proceeding (23) 23
Dissertation (20) 20
Government Document (17) 17
Publication (10) 10
Book Review (9) 9
Trade Publication Article (9) 9
Streaming Video (8) 8
Reference (6) 6
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (49140) 49140
female (23056) 23056
male (17212) 17212
antibodies, monoclonal, humanized (16691) 16691
antibodies, monoclonal - therapeutic use (15087) 15087
middle aged (13799) 13799
oncology (13515) 13515
animals (13038) 13038
monoclonal antibodies (12523) 12523
adult (11486) 11486
antibodies, monoclonal, humanized - therapeutic use (11360) 11360
aged (10460) 10460
treatment outcome (10432) 10432
cancer (8879) 8879
bevacizumab (8567) 8567
immunology (6918) 6918
antibodies (6795) 6795
mice (6724) 6724
care and treatment (6655) 6655
monoclonal-antibody (6310) 6310
therapy (6239) 6239
antibodies, monoclonal - administration & dosage (6182) 6182
antibodies, monoclonal, humanized - administration & dosage (5842) 5842
antineoplastic agents - therapeutic use (5765) 5765
research (5758) 5758
trastuzumab (5491) 5491
chemotherapy (5425) 5425
antibodies, monoclonal - adverse effects (5389) 5389
immunotherapy (5116) 5116
pharmacology & pharmacy (5102) 5102
antineoplastic combined chemotherapy protocols - therapeutic use (5032) 5032
drug therapy (4793) 4793
antibodies, monoclonal, humanized - adverse effects (4608) 4608
health aspects (4503) 4503
clinical trials (4218) 4218
medicine & public health (4048) 4048
analysis (3998) 3998
expression (3963) 3963
breast neoplasms - drug therapy (3950) 3950
aged, 80 and over (3914) 3914
antibodies, monoclonal - pharmacology (3780) 3780
angiogenesis inhibitors - therapeutic use (3734) 3734
proteins (3702) 3702
adalimumab (3524) 3524
ophthalmology (3427) 3427
cetuximab (3403) 3403
retrospective studies (3402) 3402
tumors (3343) 3343
breast cancer (3331) 3331
hematology (3314) 3314
double-blind (3229) 3229
cell line, tumor (3199) 3199
abridged index medicus (3100) 3100
vascular endothelial growth factor a - antagonists & inhibitors (3099) 3099
efficacy (3013) 3013
safety (3002) 3002
medicine, research & experimental (2961) 2961
infliximab (2886) 2886
viral antibodies (2881) 2881
rheumatology (2875) 2875
clinical trials as topic (2865) 2865
antibody (2812) 2812
patients (2807) 2807
antibodies, monoclonal - immunology (2714) 2714
metastasis (2706) 2706
immunoglobulins (2705) 2705
medical research (2615) 2615
tumor necrosis factor-alpha - antagonists & inhibitors (2549) 2549
prognosis (2535) 2535
follow-up studies (2521) 2521
young adult (2432) 2432
rituximab (2426) 2426
angiogenesis inhibitors - administration & dosage (2355) 2355
risk factors (2352) 2352
antibodies, monoclonal, humanized - pharmacology (2324) 2324
surgery (2318) 2318
adolescent (2312) 2312
antigens (2312) 2312
biological products (2311) 2311
endothelial growth-factor (2305) 2305
transplantation (2287) 2287
breast neoplasms - pathology (2264) 2264
medicine, general & internal (2248) 2248
immunosuppressive agents - therapeutic use (2246) 2246
biotechnology & applied microbiology (2220) 2220
ranibizumab (2214) 2214
disease (2183) 2183
trial (2180) 2180
time factors (2178) 2178
arthritis, rheumatoid - drug therapy (2169) 2169
vascular endothelial growth factor (2159) 2159
rheumatoid arthritis (2108) 2108
antineoplastic agents - pharmacology (2080) 2080
disease-free survival (2077) 2077
survival (2054) 2054
review (2023) 2023
monoclonal antibody (2012) 2012
apoptosis (1998) 1998
cytokines (1983) 1983
colorectal neoplasms - drug therapy (1969) 1969
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (18) 18
Online Resources - Online (12) 12
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Engineering & Comp. Sci. - Stacks (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (62548) 62548
Japanese (920) 920
French (643) 643
German (584) 584
Spanish (305) 305
Chinese (245) 245
Russian (94) 94
Hungarian (82) 82
Italian (76) 76
Polish (69) 69
Czech (54) 54
Danish (48) 48
Portuguese (45) 45
Dutch (35) 35
Swedish (23) 23
Finnish (19) 19
Norwegian (17) 17
Korean (16) 16
Romanian (15) 15
Hebrew (13) 13
Croatian (11) 11
Arabic (5) 5
Slovak (5) 5
Icelandic (3) 3
Serbian (3) 3
Turkish (3) 3
Lithuanian (2) 2
Bosnian (1) 1
Slovenian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Biochemical and biophysical research communications, ISSN 0006-291X, 2005, Volume 333, Issue 2, pp. 328 - 335
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2016, Volume 374, Issue 21, pp. 2044 - 2053
Journal Article
PloS one, ISSN 1932-6203, 2015, Volume 10, Issue 9, pp. e0137345 - e0137345
.... We previously found increased expression of CD47 on primary human acute myeloid leukemia (AML) stem cells, and demonstrated that blocking monoclonal antibodies directed... 
TARGET | APOPTOSIS | STEM-CELLS | PROGNOSTIC-FACTOR | MACROPHAGES | MULTIDISCIPLINARY SCIENCES | REGULATORY PROTEIN-ALPHA | CD47 | PROMOTE PHAGOCYTOSIS | CANCER | SYNERGIZES | Phagocytosis - drug effects | Antibodies, Monoclonal, Humanized - therapeutic use | Antineoplastic Agents - immunology | Leukemia, Myeloid, Acute - pathology | Humans | Antibodies, Monoclonal - pharmacokinetics | Macaca fascicularis | Antibodies, Monoclonal - therapeutic use | Antibody Affinity | Antineoplastic Agents - therapeutic use | Leukemia, Myeloid, Acute - immunology | CD47 Antigen - immunology | Haplorhini | Rituximab - therapeutic use | Animals | Antibodies, Monoclonal, Humanized - pharmacokinetics | Leukemia, Myeloid, Acute - drug therapy | Female | Antineoplastic Agents - pharmacokinetics | Mice | Mice, Inbred BALB C | Tumor Cells, Cultured | Antibodies, Monoclonal, Humanized - immunology | Antibodies, Monoclonal - immunology | Monoclonal antibodies | Physiological aspects | Genetic aspects | Research | Non-Hodgkin's lymphomas | Drug therapy | Animal models | Leukemia | Immunoglobulin G | Xenotransplantation | Clinical trials | Stem cell transplantation | Biology | Macrophages | Cancer therapies | Cell surface | Proteins | Signal transduction | Allografts | Xenografts | Primates | Chemical bonds | Bone marrow | Chief executive officers | Drug dosages | Immune system | Medical research | Complementarity | Dendritic cells | Myeloid leukemia | Rituximab | Lymphoma | Medicine | Serum levels | Chemotherapy | Medical prognosis | Stem cells | Solid tumors | Acute myeloid leukemia | Phagocytosis | Cancer | Apoptosis | Tumors | Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2013, Volume 369, Issue 8, pp. 711 - 721
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 02/2015, Volume 290, Issue 7, pp. 4059 - 4074
Journal Article
Virology, ISSN 0042-6822, 2013, Volume 435, Issue 1, pp. 14 - 28
.... In this regard humanized mice (hu-Mice) have played an important role in our understanding of viral pathogenesis and testing of therapeutic strategies... 
Infectious Disease | HIV-1 in humanized mice | HIV-1 vaginal and rectal mucosal transmission | Drug testing in humanized mice | Gene therapy in humanized mice | HIV therapies and prevention using humanized mice | Antibody responses in humanized mice | Immune responses in humanized mice | Monoclonal antibodies in humanized mice | T cell responses in humanized mice | Dengue, HCV, and EBV in humanized mice | Novel siRNA and aptamer therapies in humanized mice | Comparisons of humanized mice | HIV-1 latency in humanized mice | PROGRESSIVE HIV-1 INFECTION | transmission Novel siRNA and aptamer therapies in | HIV-1 vaginal and rectal mucosal | HUMAN-IMMUNODEFICIENCY-VIRUS | NSG-BLT MICE | REGULATORY PROTEIN ALPHA | T-CELL RESPONSES | VIROLOGY | HEMATOPOIETIC STEM-CELLS | HIV therapies and prevention using | HUMAN IMMUNE-SYSTEM | EPSTEIN-BARR-VIRUS | humanized mice | SCID IL2R-GAMMA(NULL) MICE | RAG-HU MICE | Immunoglobulins | Virus Diseases - immunology | Humans | HLA Antigens - immunology | Hematopoietic Stem Cell Transplantation | Transplantation, Heterologous | Virus Diseases - virology | Viruses - immunology | HLA Antigens - genetics | Mice, Transgenic - immunology | T-Lymphocytes - virology | Thymus Gland - virology | Founder Effect | Animals | T-Lymphocytes - immunology | Thymus Gland - immunology | Mice | Liver Transplantation - immunology | Mice, Transgenic - virology | Immunoglobulin Class Switching | Disease Models, Animal | Antiviral agents | Biological products | Immunoglobulin G | Transplantation | T cells | HIV (Viruses) | Hematopoietic stem cells | Virus diseases | Disease transmission | Physiological aspects | HIV testing | Monoclonal antibodies | Comparative analysis | Hepatitis C virus | Health aspects | transmission | Novel siRNA and aptamer therapies in
Journal Article